The Centers for Medicare & Medicaid Services should determine the extent to which state Medicaid programs comply with federal requirements to cover medication-assisted treatment in all formats, and take actions as appropriate to ensure compliance, the Government Accountability Office said in a report released today. Congress asked GAO to review access barriers to MAT medications. GAO found that some state policies, such as prior authorization requirements and mandated distribution methods, can restrict Medicaid beneficiaries' access to MAT. 

Related News Articles

Headline
The AHA today released the Health Plan Accountability Update for the third quarter of 2025. The update covers the latest developments in Medicare…
Headline
The AHA Oct. 3 responded to the Medicare Payment Advisory Commission’s recent analysis on the financial impacts of Medicare Advantage enrollment growth on…
Headline
A JAMA study published yesterday analyzed the health characteristics of individuals projected to lose Medicaid coverage due to work requirements included in…
Headline
The Centers for Medicare & Medicaid Services Sept. 30 released guidance to states clarifying its interpretation of a provision that…
Headline
An analysis published Sept. 30 by KFF found that Health Insurance Marketplace enrollees who currently benefit from the enhanced premium tax credits would pay…
Headline
President Trump today announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by…